Ardian nabs $30M to treat heart failure
Ardian, maker of a device used to treat symptoms of congestive heart failure, just brought in $30 million of an anticipated $60 million third round of capital, according to peHUB. Backers of the Menlo Park, Calif. company include Advanced Technology Ventures, Morgenthaler Ventures and St. Paul Venture Capital. It previously raised $18 million.
Founded in 2003, the tiny, web site-less firm was initially incubated at the Foundry.
Next Story: Return Path seals $6M for email management
Previous Story: Supposed leaked Android G2 shots reveal no keyboard
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.